Adjuvant conversion to sirolimus in liver transplant patients with recurrent hepatocellular carcinoma - preliminary results.
Kornberg
A
A
Küpper
B
B
Tannapfel
A
A
Thrum
K
K
Wilberg
J
J
Bärthel
E
E
Settmacher
U
U
D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy*; D016031:Liver Transplantation; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D020123:Sirolimus / Q000627:therapeutic use*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D020123:Sirolimus